A carregar...
Tenecteplase versus Alteplase for the Management of Acute Ischemic Stroke in a Low-income Country–Nepal: Cost, Efficacy, and Safety
Intravenous alteplase is the only approved treatment for acute ischemic stroke. Tenecteplase, a genetically engineered, mutant tissue plasminogen activator, is an alternative thrombolytic agent. The economic feasibility of stroke treatment has been a matter of huge debate and discussion thus far. Th...
Na minha lista:
| Publicado no: | Cureus |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Cureus
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5890961/ https://ncbi.nlm.nih.gov/pubmed/29651371 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.2178 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|